N atural killer cells recognize abnormal or allogeneic cells by using a repertoire of receptors that regulates their activation and effector functions (1) . NK cells have adaptive immune features, which include differentiation into selfrenewing memory cells after exposure to mouse CMV (MCMV), haptens, cytokines, and alloantigens (2) (3) (4) (5) (6) . In humans, NKG2C high NK cells have been identified as memory NK cells based on their specific expansion and persistence for months following human CMV infection (3, 7, 8) . Mouse NK cells expressing Ly49H, which recognizes the m157 MCMV glycoprotein on infected cells (9) , undergo clonal expansion, contraction, and differentiation into memory cells after MCMV infection (5) . The DAP12 and DAP10 adaptor proteins and the costimulatory DNAM-1 receptor are required for optimal expansion of Ly49H + NK cells and their differentiation into memory cells (5, 10) . IL-12 is essential for both expansion and memory generation (11) ; however, the roles of other cytokines for adaptive immune responses mediated by NK cells are largely unknown.
IL-33, a member of the IL-1 cytokine family (12) , is expressed constitutively by endothelial and epithelial cells and by fibroblastic reticular cells (FRCs) in secondary lymphoid organs (13) . It is released upon tissue damage and necrosis, thus acting as an early inducer of inflammation, and it exacerbates Th2 immune responses in mouse models of arthritis and asthma (14) . Binding of IL-33 to its receptor ST2 induces MyD88-dependent activation of NF-kB and MAPK (14) . ST2 is expressed on many immune cells (12, 15, 16) , and the IL-33/ST2 signaling pathway augments IL-12-induced IFN-g production by NK cells (15, 16) . ST2 is essential for control of coxsackievirus B5-induced pancreatitis by enhancing IFN-g production by NK cells, which is associated with viral clearance (17) . In the present study, we investigated the role of the IL-33/ ST2 signaling axis in the adaptive immune response of NK cells during MCMV infection.
Materials and Methods

Mice and MCMV
C57BL/6 and congenic CD45.1 + C57BL/6 mice were purchased from the National Cancer Institute. C57BL/6 ST2-deficient (Il1rl1 2/2 mixed bone marrow (BM) chimeric mice were generated as described (5) . Smith strain MCMV was prepared as described (6) 
Flow cytometry
Fc receptors were blocked with 2.4G2 mAb before staining with the indicated mAbs or isotype-matched control Abs (BD Biosciences, eBioscience, or BioLegend). Samples were acquired on an LSR II (BD Biosciences) and analyzed with FlowJo software (Tree Star).
In vitro stimulation and proliferation of NK cells
One million splenocytes from mixed BM chimeric mice were incubated in 96-well tissue culture plates coated with anti-NKp46 (29A1.4) as described (5), or with 10 ng/ml mouse IL-12 plus 10 ng/ml mouse IL-18 (R&D Systems), 10 ng/ml PMA plus 1 mg/ml ionomycin (Sigma-Aldrich), or cocultured with 1 3 10 5 RMA or m157-transfected RMA cells as described (6) . One million CellTrace Violet-labeled splenocytes were cocultured with 1 3 10 5 RMA or m157-transfected RMA cells (fixed in 1% paraformaldehyde) in the absence or presence of 25 ng/ml mouse IL-33 (R&D Systems) and/or 10 ng/ml mouse IL-12 with 50 U/ml human IL-2 (National Cancer Institute) for 4 d at 37˚C.
Viral load
Ten thousand naive or memory Ly49H + NK cells were transferred separately into Ly49H-deficient or DAP12-deficient mice and infected with MCMV. Peripheral blood was collected on day 4 postinfection (p.i.), and the right lobe of liver and the spleen were homogenized in DMEM with 10% FCS on day 7 p.i. and DNA was isolated from these specimens. The copy number of MCMV IE1 gene in blood, spleen, and liver was determined as described (10) . The copy number of MCMV IE1 gene in the spleen was calculated for the whole organ and the copy number of MCMV IE1 in the liver was adjusted for weight of the tissue.
IL-33 in splenic stromal cells
Splenic stromal cells were prepared as described with minor modifications (21) . Spleens were digested with 0.2 U/ml dispase, 0.2 mg/ml collagenase D, and 0.1 mg/ml DNase I (Roche), and stromal cells were enriched by depletion with mAbs against CD4, CD8, CD11b, CD19, and Ter119, and magnetic separation with anti-rat IgG-coated beads (Qiagen). FRCs (CD31 
Statistical analysis
The Student t test was used to compare results. The Mann-Whitney U test was used to compare MCMV viral titers. Error bars represent SEM.
Results
ST2 is dispensable for NK cell development
To determine whether an intrinsic lack of ST2 affects NK cell development and function, we reconstituted lethally irradiated recipient mice with CD45. (Fig. 2D, 2E) .
and stained for annexin V early after infection comparably to WT mice ( Fig. 2F-H (Fig. 2I, 2J ). These findings demonstrate that ST2 and IL-33 are dispensable for activation, IFN-g production, and survival of NK cells, but they augment expansion of Ly49H + NK cells during MCMV infection.
ST2 enhances expansion of naive and memory Ly49H
+ NK cells and control of MCMV
WT and Il1rl1
2/2 Ly49H + NK cells from BM chimeric mice were adoptively transferred into Ly49H-deficient recipient mice and infected with MCMV. Il1rl1 2/2 Ly49H + NK cells proliferated less than did WT Ly49H + NK cells in the spleen and liver at the peak of the NK cell response on day 7 p.i. (Fig. 3A, 3B) (Fig. 3C ). WT and Il1rl1
2/2
Ly49H + NK cells adoptively transferred into Ly49H-deficient recipient mice generated a long-lived subset in the blood and spleen 1 mo p.i. with MCMV (Fig. 3D, 3E ), although Il1rl1 2/2 Ly49H + NK cells showed pronounced impairment in expansion in the blood on day 7 p.i. (Fig. 3D) 5 PFU MCMV. The copy number of MCMV IE1 gene in the blood (H) on day 4 p.i. and in the spleen (I) and liver (J) on day 7 p.i. was analyzed by quantitative PCR. (H) Data were pooled from four experiments (n = 7-11 mice/group) and (I and J) data were pooled from two experiments (n = 4 mice/group). *p , 0.05, ***p , 0.005.
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Ly49H
+ NK cells adoptively transferred into Ly49H-deficient mice or DAP12-deficient mice, which lack functionally competent Ly49H + NK cells and are unable to control early replication of MCMV (5), showed a poor protective effect against MCMV challenge compared with WT Ly49H + NK cells in the blood, spleen, and liver, consistent with the impaired proliferation of Il1rl1 2/2 Ly49H + NK cells (Fig. 3H-J) . Thus, ST2 is necessary not only for the optimal expansion of naive and memory Ly49H + NK cells during MCMV infection, but also for efficient control of MCMV.
Splenic stromal cells upregulate IL-33 during MCMV infection
FRCs, a stromal cell subset in secondary lymphoid organs, constitutively express IL-33, and IL-33 is upregulated in inflamed tissues (13) . We investigated whether stromal cell subsets modulate expression of IL-33 during MCMV infection. Frequencies of splenic stromal cell subsets, as determined by staining CD45 2 cells with CD31 and gp38, did not change dramatically during MCMV infection (data not shown). However, FRCs, LEC-like cells, and double-negative cells, but not blood endothelial cells, highly upregulated IL-33 transcripts in the early course of infection (Fig. 4) .
IL-33 enhances m157-dependent proliferation of Ly49H
+ NK cells IL-33 synergizes with IL-12 for IFN-g production by NK cells (15, 16) . To address whether IL-33 has a direct effect on proliferation, WT and Il1rl1 2/2 Ly49H + NK cells were cocultured with RMA or m157-transfected RMA cells in the absence or presence of IL-12 and IL-33 with a low dose IL-2. IL-33 had little impact on Ag nonspecific cell divisions of Ly49H + NK cells induced by IL-2, or the m157-driven proliferation of Ly49H + NK cells in the absence of IL-12 (Fig. 5A , 5B). Alternatively, in the presence of IL-12, IL-33 enhanced proliferation of WT Ly49H + NK cells, but not Il1rl1 2/2 Ly49H + NK cells (Fig. 5C, 5D ).
Discussion
The quantity of bioactive IL-33 is transcriptionally and posttranslationally regulated (12, 14) . IL-33 transcription is induced by poly(I:C), an agonist of TLR3, which is essential in the innate immune defense against MCMV (22, 23) . IL-33 is released by tissue damage or infection and subsequently cleaved into the biological active form by proteases released during inflammation (12) . A previous study using an MCMV strain encoding GFP has demonstrated that MCMV infects FRCs and spreads in the spleen within 48 h p.i. (24) . Interestingly, NK cells migrate to the white pulp of the spleen and are in contact with FRCs within the T cell area by 24 h after MCMV infection, prior to the expansion of Ly49H + NK cells (25) . Taken together, a high concentration of bioactive IL-33 at the local interface of NK cells with stromal cells would ensure efficient ST2 signaling in NK cells, which may contribute to the preferential expansion of Ly49H + NK cells. An IL-12/STAT4 signaling pathway is critical for both expansion and memory generation of NK cells in response to MCMV infection and alloantigen stimulation (6, 11) . Unlike IL-12, the IL-33/ST2 signaling pathway augments the expansion of Ly49H + NK cells, but it is not required for differentiation into memory cells. Although IL-33 synergizes with IL-12 for IFN-g production by NK cells in vitro (15, 16) , production of IFN-g by NK cells in vivo early after MCMV infection does not require IL-33 or ST2, indicating that other cytokines produced during infection might compensate. Moreover, previously we demonstrated that Ly49H + NK cells do not require IFN-g to undergo expansion during MCMV infection (11) , suggesting that the robust proliferation of NK cells requires IL-12-dependent signals and is enhanced by IL-33-dependent signals, but not IFN-g-mediated signaling. Both IL-12-deficient and STAT4-deficient Ly49H + NK cells have a severe defect in expansion during MCMV infection (11) , whereas an IL-33/ST2 signaling deficiency has a lesser impact. IL-18 and IL-1b, which are other members of the IL-1 cytokine family, are known to synergize with IL-12 for IFN-g production by NK cells in vitro and in vivo (15, 16, 26) . A recent study has demonstrated that an IL-18/IL-18R signaling axis is required for the optimal IFN-g production, expansion, and memory differentiation of Ly49H + NK cells during MCMV infection (27) . The authors show that MyD88-deficient Ly49H + NK cells exhibit the same defects as IL-18R-deficient Ly49H + NK cells (27) . In contrast, IL-1R-deficient Ly49H + NK cells normally expand and differentiate into memory NK cells after the infection (27) . In the present study, ST2-deficient Ly49H + NK cells exhibit impairment in MCMVspecific expansion of naive and memory Ly49H + NK cells, but neither in IFN-g production nor in differentiation into memory NK cells. Interestingly, IL-18R signaling is dispensable for the secondary expansion of memory Ly49H + NK cells when rechallenged with MCMV. These results suggest that IL-33 is released by damaged cells in the early phase of MCMV infection and that ST2 signaling transiently enhances MyD88 signaling to augment the proliferation of naive and memory Ly49H + NK cells, whereas IL-18 more broadly impacts NK cell responses in the course of MCMV infection.
Our findings indicate that multiple cytokines and their downstream signaling pathways differentially modulate the adaptive immune features of NK cells. Further studies of spatiotemporal regulation of cytokine production, as well as the adaptor molecules through which cytokine receptors signal, will be required to understand fully the molecular mechanisms underlying the differentiation of memory NK cells.
